Table 1.
Patients’ characteristics (n = 18)
| Age (years) | 72 (67, 75) |
|---|---|
| Female | 12 (67%) |
| Ethnicity: Caucasian | 18 (100%) |
| BMI (kg/m2) | 24 (23, 26) |
| Prior GCs treatmenta | 11 (61%) |
| Days since GCA symptom onset | 28 (21, 59) |
| CRP at screening (mg/l) | 61 (50, 78) |
| CRP at baseline (mg/l) | 44 (18, 62) |
| ESR at screening (mm/h) | 83 (61, 89) |
| ESR at baseline (mm/h) | 71 (44, 79) |
| Cranial symptoms | 15 (83%) |
| Headache | 12 (67%) |
| Jaw claudication | 10 (56%) |
| Visual symptoms | 6 (33%) |
| PMR symptoms | 10 (56%) |
| Weight loss >2 kg/4 weeks | 6 (33%) |
| Positive TA US | 16 (89%) |
| Aortitis on MRI | 14 (78%) |
| Vasculitis on cranial MRI | 14 (78%) |
| Positive histology (inflammatory infiltrate) | 13 (72%) |
a
for a median of 1 (min 1, max 7) days. Values are n (%, referring to 18) or median (lower quartile, upper quartile). GCs: glucocorticoids; TA: temporal artery.